Nyumbani › Ugonjwa wa Crohn
Majaribio ya kliniki ya Ugonjwa wa Crohn yanayovutia washiriki nchini Marekani
Masomo 93 ya Ugonjwa wa Crohn yanavutia washiriki katika vituo vya Marekani nzima.
Miji yenye masomo mengi
- New York City, NYUtafiti 35
- St. Louis, MOUtafiti 19
- Cleveland, OHUtafiti 19
- Boston, MAUtafiti 19
- Miami, FLUtafiti 19
- Orlando, FLUtafiti 17
- Houston, TXUtafiti 17
- Atlanta, GAUtafiti 17
- Tyler, TXUtafiti 16
- San Diego, CAUtafiti 15
- San Antonio, TXUtafiti 15
- Los Angeles, CAUtafiti 15
- Philadelphia, PAUtafiti 13
- Colorado Springs, COUtafiti 13
- Durham, NCUtafiti 12
- Providence, RIUtafiti 12
- Tacoma, WAUtafiti 11
- Pittsburgh, PAUtafiti 11
- Seattle, WAUtafiti 11
- Cincinnati, OHUtafiti 11
- Baltimore, MDUtafiti 10
- Washington, DCUtafiti 10
- Indianapolis, INUtafiti 10
- Dallas, TXUtafiti 10
- Tampa, FLUtafiti 10
- Lubbock, TXUtafiti 10
- Ann Arbor, MIUtafiti 9
- Chicago, ILUtafiti 9
- Louisville, KYUtafiti 9
- Lewisville, TXUtafiti 9
- Evanston, ILUtafiti 9
- Rochester, MNUtafiti 8
- Parma, OHUtafiti 8
- Columbus, OHUtafiti 8
- New Haven, CTUtafiti 8
- Charlotte, NCUtafiti 8
- Independence, MOUtafiti 8
- Milwaukee, WIUtafiti 7
- Lafayette, LAUtafiti 7
- Queens, NYUtafiti 7
Kwa jimbo
- AlabamaUtafiti 9
- ArizonaUtafiti 17
- ArkansasUtafiti 3
- CaliforniaUtafiti 37
- ColoradoUtafiti 18
- ConnecticutUtafiti 14
- FloridaUtafiti 27
- GeorgiaUtafiti 22
- IdahoUtafiti 4
- IllinoisUtafiti 18
- IndianaUtafiti 13
- IowaUtafiti 8
- KansasUtafiti 11
- KentuckyUtafiti 12
- LouisianaUtafiti 11
- MarylandUtafiti 15
- MassachusettsUtafiti 27
- MichiganUtafiti 20
- MinnesotaUtafiti 11
- MississippiUtafiti 3
- MissouriUtafiti 21
- NevadaUtafiti 8
- New HampshireUtafiti 3
- New JerseyUtafiti 9
- New YorkUtafiti 36
- North CarolinaUtafiti 20
- OhioUtafiti 30
- OklahomaUtafiti 8
- OregonUtafiti 4
- PennsylvaniaUtafiti 23
- Rhode IslandUtafiti 12
- South CarolinaUtafiti 11
- South DakotaUtafiti 4
- TennesseeUtafiti 10
- TexasUtafiti 35
- UtahUtafiti 8
- VirginiaUtafiti 15
- WashingtonUtafiti 22
- Wilaya ya ColumbiaUtafiti 4
- WisconsinUtafiti 7
Masomo yaliyosasishwa hivi karibuni
Maandishi rasmi ya utafiti (Kiingereza)
Longitudinal Immunophenotyping of Patients With Inflammatory Bowel Disease
InaajiriUtafiti wa uchunguzi
Umri 18 hadi 85 · Jinsia zote · Imesasishwa 2 Okt 2026 · NCT07619547Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
InaajiriHatua 3
Umri wote · Jinsia zote · Imesasishwa 2 Okt 2026 · NCT06651281A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
InaajiriHatua 3
Umri 16 hadi 80 · Jinsia zote · Imesasishwa 2 Okt 2026 · NCT06430801Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
InaajiriHatua 2
Umri 18 hadi 75 · Jinsia zote · Imesasishwa 2 Okt 2026 · NCT07697456Feasibility of a Wireless Thermal Capsule Endoscopy to Detect Gastrointestinal Thermal Variance
InaajiriWajitolea wenye afya wanakaribishwa
Umri 18 hadi 75 · Jinsia zote · Imesasishwa 2 Okt 2026 · NCT07033208Investigating the Effect of the Non-nutritive Sweetener Sucralose in Inflammatory Bowel Disease
InaajiriWajitolea wenye afya wanakaribishwa
Umri 18 hadi 75 · Jinsia zote · Imesasishwa 1 Okt 2026 · NCT07852273A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
InaajiriHatua 4
Umri 18 hadi 80 · Jinsia zote · Imesasishwa 30 Sep 2026 · NCT06581328Non-nutritive Sweeteners in Inflammatory Bowel Disease
InaajiriWajitolea wenye afya wanakaribishwa
Umri 18 hadi 70 · Jinsia zote · Imesasishwa 25 Sep 2026 · NCT07769437A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
InaajiriHatua 3
Umri 2 hadi 17 · Jinsia zote · Imesasishwa 25 Sep 2026 · NCT05923073Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
InaajiriHatua 2
Umri 18 hadi 75 · Jinsia zote · Imesasishwa 25 Sep 2026 · NCT06548542A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 25 Sep 2026 · NCT07499232A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
InaajiriHatua 2/3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 25 Sep 2026 · NCT07196722A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
InaajiriHatua 3
Umri 3 na zaidi · Jinsia zote · Imesasishwa 25 Sep 2026 · NCT06663332A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
InaajiriHatua 2
Umri 18 hadi 75 · Jinsia zote · Imesasishwa 25 Sep 2026 · NCT06233461Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
InaajiriHatua 3
Umri 18 hadi 70 · Jinsia zote · Imesasishwa 24 Sep 2026 · NCT06937099Tailored Anti-Inflammatory American Diet for Patients With Crohn's Disease
Inaajiri
Umri 16 hadi 75 · Jinsia zote · Imesasishwa 24 Sep 2026 · NCT07671872Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
InaajiriHatua 1
Umri 18 na zaidi · Jinsia zote · Imesasishwa 23 Sep 2026 · NCT03816345An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
InaajiriHatua 3
Umri 16 hadi 80 · Jinsia zote · Imesasishwa 23 Sep 2026 · NCT07184931A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
InaajiriHatua 3
Umri 16 hadi 80 · Jinsia zote · Imesasishwa 23 Sep 2026 · NCT07184944A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease
InaajiriHatua 3
Umri 2 hadi 17 · Jinsia zote · Imesasishwa 23 Sep 2026 · NCT05995353A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
InaajiriHatua 2
Umri 18 hadi 85 · Jinsia zote · Imesasishwa 22 Sep 2026 · NCT06226883A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
InaajiriHatua 2
Umri 18 hadi 80 · Jinsia zote · Imesasishwa 22 Sep 2026 · NCT07483073A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
InaajiriHatua 3
Umri 2 hadi 19 · Jinsia zote · Imesasishwa 22 Sep 2026 · NCT04844606A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease
InaajiriHatua 2
Umri 18 hadi 80 · Jinsia zote · Imesasishwa 22 Sep 2026 · NCT07483099A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
InaajiriHatua 4
Umri 18 hadi 70 · Jinsia zote · Imesasishwa 9 Sep 2026 · NCT06045754Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.